Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S9700: 5-FU, Leucovorin, Mitomycin-C, and Dipyridamole in Pancreatic Cancer
NCT00003018Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 1997
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dipyridamole in pancreatic adenocarcinoma (PDAC), sponsored by SWOG Cancer Research Network. Started Sep 1997; status: completed.
02
Drugs
dipyridamole
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00003018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003018.